Markets may open lower amid global trade tensions and growth concerns
Markets may open lower amid global trade tensions and growth concerns

Markets may open lower amid global trade tensions and growth concerns

Karan Dsij Article rating: 5.0

Considering the early action in SGX Nifty and the Asian peers, it appears that the Indian benchmark indices are expected to open lower. Digging deeper, scaring the market participants the most is the global growth forecast from IMF as it cut global growth outlook amidst global trade tensions. Also, the US President Donald Trump threatened to impose tariffs on $11 billion worth of European Union (EU) products and the latest statement from the EU suggests these countries will retaliate. At the time of writing, SGX Nifty was trading around 11,709 levels down by 40 points.

Market rebounds, up 238 points
Market rebounds, up 238 points

Market rebounds, up 238 points

Gayathri Udyawar Article rating: 5.0

Post lunch recovery sends benchmark indices back to their highs. The BSE Sensex closed at 38,939.22, up by 238.69 points or 0.62 per cent, while Nifty50 ended the day at 11,671.95, up by 67.45 points or 0.58 per cent on Tuesday.


Overnight Digest: Stocks to look out for on April 10
Overnight Digest: Stocks to look out for on April 10

Overnight Digest: Stocks to look out for on April 10

Shohini Nath Article rating: 3.3

The stocks that are likely to witness significant movement on the bourses on April 10 are Bharat Forge, Sundram Fasteners, Tech Mahindra, GSFC and Praj Industries

GSFC to undergo maintenance shutdown
GSFC to undergo maintenance shutdown

GSFC to undergo maintenance shutdown

Amir Shaikh Article rating: 5.0

Gujarat State Fertilizers and Chemicals (GSFC) informed the bourses today that it will start annual shutdown of Ammonia - IV plant of Baroda Unit from April 13, 2019 for a period of 50 days.

Shilpa Medicare receives approval for Bortezomib for Injection
Shilpa Medicare receives approval for Bortezomib for Injection

Shilpa Medicare receives approval for Bortezomib for Injection

Advait Dharmadhikari Article rating: 4.0

Shilpa Medicare has received a tentative approval for its ANDA , Bortezomib for Injection, 3.5mg/vial from the USFDA. Bortezomib for Injection, 3.5mg/vial is a generic equivalent of reference listed drug (RLD), VELCADE used in the treatment of patients with multiple myeloma and Mantle Cell Lymphoma as recommended in the label approved by the FDA.According to IQVIA MAT Q4 2018 data, the US market for Bortezomib for Injection, 3.5mg/vial is approximately US$609 million.

Is nomination enough for estate planning?
Is nomination enough for estate planning?

Is nomination enough for estate planning?

Henil Shah Article rating: 5.0

Nomination is often considered to be the first step towards estate planning. However, just having a nomination alone is not enough for wealth distribution. Let’s find out crucial aspects of effective estate planning.

Sobha records strong business performance for Q4
Sobha records strong business performance for Q4

Sobha records strong business performance for Q4

Amir Shaikh Article rating: 3.5

Sobha Limited announced its fourth quarter business update for FY19, on Monday. The company clocked a sales volume of 1,129,268 square feet in Q4FY19 worth Rs. 920.5 crore. The sales value for the quarter was up by nearly 13.3 per cent from the corresponding quarter of the previous year. 

JSW Steel achieves 16.69 MT production
JSW Steel achieves 16.69 MT production

JSW Steel achieves 16.69 MT production

Amir Shaikh Article rating: 3.7

JSW Steel reported a crude steel production of 16.69 million tons (MT) in FY19, registering a growth of 3 per cent over the corresponding period of the previous year. With this, the company achieved 99.6 per cent of its production guidance of 16.75 Million tonnes, given at the start of FY19.

Ten stocks close to their 52-weeks high
Ten stocks close to their 52-weeks high

Ten stocks close to their 52-weeks high

Shital Jibhe Article rating: 5.0

The markets on April 09, 2019 opened gap down. BSE Sensex is trading at 38,656.41, down by 44.12 points and the Nifty is trading at 11,589.85, down by 14.65 points. 

RSS
First31313132313331343136313831393140Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR